Lei Wang

8.8k citations
310 papers · 6.5k indexed · 1 hit paper · h-index 42
Topics
MicroRNA in disease regulation (29 papers)Immune Response and Inflammation (25 papers)Ubiquitin and proteasome pathways (23 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Lei Wang

296 papers receiving 6.5k citations

Hit Papers

Research Resource: Comprehensive Expression Atlas of the ...20102026201520202010100200300400500

Peers

Lei Wang
Comparison fields: 5 of 144
  • Molecular Biology 3.3k
  • Cancer Research 1.1k
  • Cardiology and Cardiovascular Medicine 871
  • Immunology 833
  • Surgery 724
Replace Xuping Wang with:
Xuping Wang China
Ying H. Shen United States
Jeanine D’Armiento United States
Jianglin Fan Japan
Jing Li China
Xian Wang China
Hongwei Wang China
Józef Dulak Poland
Ying Yu China
Cheng Zhang China
Lei Wang relative to Xuping Wang China Xuping Wang's profile →
Citations per field
00.5×1.5×2.2×
Xuping Wang · 1×
Citations per year

Countries citing papers authored by Lei Wang

Since Specialization
Citations

This map shows the geographic impact of Lei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wang more than expected).

Fields of papers citing papers by Lei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wang. The network helps show where Lei Wang may publish in the future.

Co-authorship network of co-authors of Lei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Wang. A scholar is included among the top collaborators of Lei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Wang. Lei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 8
3 1
4 1
5 1
6 4
7 14
8 8
9 5
10 13
11 12
12 22
13 6
14 15
15 1
16 23
17 1
18 1
19 1
20 45

About Lei Wang

Lei Wang is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Immunology, having authored 310 papers that have together received 6.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (29 papers), Immune Response and Inflammation (25 papers) and Ubiquitin and proteasome pathways (23 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (3.3k citations) and Immunology (833 citations). Lei Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Kent E. Pinkerton, Hui‐Hua Li, Jie Du, Angie L. Bookout, Hiroshi Kurosu, Regina Goetz, Makoto Kuro‐o, Steven A. Kliewer, David J. Mangelsdorf and Klementina Fon Tacer. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026